590 related articles for article (PubMed ID: 15501228)
1. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer.
De Val S; Anderson JP; Heidt AB; Khiem D; Xu SM; Black BL
Dev Biol; 2004 Nov; 275(2):424-34. PubMed ID: 15501228
[TBL] [Abstract][Full Text] [Related]
2. Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development.
Dodou E; Verzi MP; Anderson JP; Xu SM; Black BL
Development; 2004 Aug; 131(16):3931-42. PubMed ID: 15253934
[TBL] [Abstract][Full Text] [Related]
3. A conserved enhancer element that drives FGF4 gene expression in the embryonic myotomes is synergistically activated by GATA and bHLH proteins.
Iwahori A; Fraidenraich D; Basilico C
Dev Biol; 2004 Jun; 270(2):525-37. PubMed ID: 15183731
[TBL] [Abstract][Full Text] [Related]
4. Gata4 expression in lateral mesoderm is downstream of BMP4 and is activated directly by Forkhead and GATA transcription factors through a distal enhancer element.
Rojas A; De Val S; Heidt AB; Xu SM; Bristow J; Black BL
Development; 2005 Aug; 132(15):3405-17. PubMed ID: 15987774
[TBL] [Abstract][Full Text] [Related]
5. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
[TBL] [Abstract][Full Text] [Related]
6. Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene.
Schwachtgen JL; Janel N; Barek L; Duterque-Coquillaud M; Ghysdael J; Meyer D; Kerbiriou-Nabias D
Oncogene; 1997 Dec; 15(25):3091-102. PubMed ID: 9444957
[TBL] [Abstract][Full Text] [Related]
7. Sequence specific binding of Ets-1 to the mouse cytokeratin EndoA gene enhancer.
Hamazato F; Fujimura Y; Tamai Y; Takemoto Y; Matsushiro A; Nozaki M
Biochem Biophys Res Commun; 1993 Apr; 192(2):430-8. PubMed ID: 7683460
[TBL] [Abstract][Full Text] [Related]
8. Multiple regulatory regions control the expression of Ets-1 in the developing mouse: vascular expression conferred by intron I.
Jorcyk CL; Garrett LJ; Maroulakou IG; Watson DK; Green JE
Cell Mol Biol (Noisy-le-grand); 1997 Mar; 43(2):211-25. PubMed ID: 9130605
[TBL] [Abstract][Full Text] [Related]
9. Expression of angiopoietin-2 in endothelial cells is controlled by positive and negative regulatory promoter elements.
Hegen A; Koidl S; Weindel K; Marmé D; Augustin HG; Fiedler U
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1803-9. PubMed ID: 15284088
[TBL] [Abstract][Full Text] [Related]
10. SOX18 directly interacts with MEF2C in endothelial cells.
Hosking BM; Wang SC; Chen SL; Penning S; Koopman P; Muscat GE
Biochem Biophys Res Commun; 2001 Sep; 287(2):493-500. PubMed ID: 11554755
[TBL] [Abstract][Full Text] [Related]
11. BOP, a regulator of right ventricular heart development, is a direct transcriptional target of MEF2C in the developing heart.
Phan D; Rasmussen TL; Nakagawa O; McAnally J; Gottlieb PD; Tucker PW; Richardson JA; Bassel-Duby R; Olson EN
Development; 2005 Jun; 132(11):2669-78. PubMed ID: 15890826
[TBL] [Abstract][Full Text] [Related]
12. A single MEF2 site governs desmin transcription in both heart and skeletal muscle during mouse embryogenesis.
Kuisk IR; Li H; Tran D; Capetanaki Y
Dev Biol; 1996 Feb; 174(1):1-13. PubMed ID: 8626009
[TBL] [Abstract][Full Text] [Related]
13. Cooperative activation of atrial naturetic peptide promoter by dHAND and MEF2C.
Zang MX; Li Y; Xue LX; Jia HT; Jing H
J Cell Biochem; 2004 Dec; 93(6):1255-66. PubMed ID: 15486975
[TBL] [Abstract][Full Text] [Related]
14. Ets motifs are necessary for endothelial cell-specific expression of a 723-bp Tie-2 promoter/enhancer in Hprt targeted transgenic mice.
Minami T; Kuivenhoven JA; Evans V; Kodama T; Rosenberg RD; Aird WC
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2041-7. PubMed ID: 12893685
[TBL] [Abstract][Full Text] [Related]
15. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains.
Kim WY; Sieweke M; Ogawa E; Wee HJ; Englmeier U; Graf T; Ito Y
EMBO J; 1999 Mar; 18(6):1609-20. PubMed ID: 10075931
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of human angiopoietin-2 by transcription factor Ets-1.
Hasegawa Y; Abe M; Yamazaki T; Niizeki O; Shiiba K; Sasaki I; Sato Y
Biochem Biophys Res Commun; 2004 Mar; 316(1):52-8. PubMed ID: 15003510
[TBL] [Abstract][Full Text] [Related]
17. The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation.
Wasylyk B; Wasylyk C; Flores P; Begue A; Leprince D; Stehelin D
Nature; 1990 Jul; 346(6280):191-3. PubMed ID: 2114554
[TBL] [Abstract][Full Text] [Related]
18. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation.
Ma K; Chan JK; Zhu G; Wu Z
Mol Cell Biol; 2005 May; 25(9):3575-82. PubMed ID: 15831463
[TBL] [Abstract][Full Text] [Related]
19. Transcription of the myogenic regulatory gene Mef2 in cardiac, somatic, and visceral muscle cell lineages is regulated by a Tinman-dependent core enhancer.
Cripps RM; Zhao B; Olson EN
Dev Biol; 1999 Nov; 215(2):420-30. PubMed ID: 10545248
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues.
Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S
Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
